http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006003697-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
filingDate 2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ad928238c42e464cd56f20a556f1602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84b5552d531d950e5078896549f89dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5dc15bb72576569fd78a952c6671b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca074d3abda9236fa34e04d87217fad
publicationDate 2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-102006003697-A1
titleOfInvention Use as a medicine
abstract The present invention relates to the use of beta-agonists of general formula 1: wherein the radicals R 1 to R 12 have the meanings mentioned in the claims and the description, and their tautomers, racemates, enantiomers, diastereomers and their mixtures, and their pharmacologically acceptable acid addition salts, for the preparation of a medicament for the treatment of the overactive bladder.
priorityDate 2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415838535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419705795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID524190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12313776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415069749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12443366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID418641503
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10197612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412630162

Total number of triples: 56.